UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study

Frontiers in immunology, 2019-02, Vol.10, p.233-233

2019

Volltextzugriff (PDF)

Anti-Tat immunity defines CD4+ T-cell dynamics in people living with HIV on long-term cART

EBioMedicine, 2021-04, Vol.66, p.103306-103306, Article 103306

2021

Volltextzugriff (PDF)

Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study

The Journal of infection, 2020-10, Vol.81 (4), p.647-679

2020

Volltextzugriff (PDF)

BOLD cardiorespiratory pulsatility in the brain: from noise to signal of interest

Frontiers in human neuroscience, 2024-01, Vol.17, p.1327276

2024

Volltextzugriff (PDF)

Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19)

The Journal of infection, 2021-08, Vol.83 (2), p.237-279

2021

Volltextzugriff (PDF)

Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort)

Viruses, 2023-02, Vol.15 (2), p.438

2023

Volltextzugriff (PDF)

Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial

Journal of acquired immune deficiency syndromes (1999), 2018-12, Vol.79 (4), p.481-490

2018

Volltextzugriff (PDF)

Soluble urokinase Plasminogen Activator Receptor (suPAR) levels are predictive of COVID-19 severity: an Italian experience

Clinical immunology (Orlando, Fla.), 2022-09, Vol.242, p.109091-109091, Article 109091

2022

Volltextzugriff (PDF)

Potential role of IgM-enriched immunoglobulin as adjuvant treatment for invasive meningococcal disease

Intensive care medicine, 2018-02, Vol.44 (2), p.261-262

2018

Volltextzugriff (PDF)

Toscana virus (TOSV) meningitis with atypical characteristics: Report of two cases

IDCases, 2024-01, Vol.37, p.e02034, Article e02034

2024

Volltextzugriff (PDF)

An Eye Tracker based Computer System to Support Oculomotor and Attention Deficit Investigations

2017 IEEE 30th International Symposium on Computer-Based Medical Systems (CBMS), 2017, p.538-543

2017

Volltextzugriff (PDF)

Exploratory Analysis for the Evaluation of Estimated Glomerular Filtration Rate, Cholesterol and Triglycerides after Switching from Tenofovir/Emtricitabine plus Atazanavir/Ritonavir (ATV/r) to Abacavir/Lamivudine plus ATV/r in Patients with Preserved Renal Function

The open AIDS journal, 2016, Vol.10, p.136-143

2016

Volltextzugriff (PDF)

Frequency and Treatment-Related Predictors of Thymidine-Analogue Mutation Patterns in HIV-1 Isolates after Unsuccessful Antiretroviral Therapy

The Journal of infectious diseases, 2006-05, Vol.193 (9), p.1219-1222

2006

Volltextzugriff (PDF)

Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received

AIDS research and therapy, 2012-06, Vol.9 (1), p.18-18, Article 18

2012

Volltextzugriff (PDF)

Neurological Symptoms during Primary Human Immunodeficiency Virus (HIV) Infection Correlate with High Levels of HIV RNA in Cerebrospinal Fluid

Clinical infectious diseases, 2000-06, Vol.30 (6), p.962-965

2000

Volltextzugriff (PDF)

Risk factors in the development of retinopathy of prematurity: A 10-year retrospective study

Early human development, 2023-10, Vol.185, p.105844-105844, Article 105844

2023

Volltextzugriff (PDF)

Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial

Journal of antimicrobial chemotherapy, 2017-07, Vol.72 (7), p.2055-2059

2017

Volltextzugriff (PDF)

Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients: ATLAS-M substudy

Journal of antimicrobial chemotherapy, 2018-07, Vol.73 (7), p.1949-1954

2018

Volltextzugriff (PDF)

Determinants of HIV-1 genotypic resistance to darunavir (TMC114) in a large Italian resistance database (Antiretroviral Resistance Cohort Analysis)

Journal of acquired immune deficiency syndromes (1999), 2007-11, Vol.46 (3), p.373-375

2007

Volltextzugriff (PDF)

Ocular involvement in neuroblastoma: not always metastasis

The lancet oncology, 2004-05, Vol.5 (5), p.324-324

2004

Volltextzugriff (PDF)

Predictors of poor outcome in tocilizumab treated patients with Sars-CoV-2 related severe respiratory failure: A multicentre real world study

International immunopharmacology, 2022-06, Vol.107, p.108709-108709, Article 108709

2022

Volltextzugriff (PDF)

Influence of hepatitis c genotypes on lipid levels in HIV-positive patients during highly active antiretroviral therapy

Antiviral therapy, 2006-01, Vol.11 (4), p.521-527

2006

Volltextzugriff (PDF)

O-16 Resting-state functional cortical connectivity are abnormal in HIV patients

Clinical neurophysiology, 2019-07, Vol.130 (7), p.e26-e26

2019

Volltextzugriff (PDF)

Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study

Medicine (Baltimore), 2016-07, Vol.95 (29), p.e4091

2016

Volltextzugriff (PDF)

Maraviroc 150 mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN study

Clinical microbiology and infection, 2015-05, Vol.21 (5), p.510.e1-510.e9

2015

Volltextzugriff (PDF)

1 – 25 von 847

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(753)
Mit Volltextzugriff
(703)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(18)

Menü

Weitere Dienste

Einstellungen

Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study

Anti-Tat immunity defines CD4+ T-cell dynamics in people living with HIV on long-term cART

Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study

BOLD cardiorespiratory pulsatility in the brain: from noise to signal of interest

Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19)

Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort)

Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial

Soluble urokinase Plasminogen Activator Receptor (suPAR) levels are predictive of COVID-19 severity: an Italian experience

Potential role of IgM-enriched immunoglobulin as adjuvant treatment for invasive meningococcal disease

Toscana virus (TOSV) meningitis with atypical characteristics: Report of two cases

An Eye Tracker based Computer System to Support Oculomotor and Attention Deficit Investigations

Exploratory Analysis for the Evaluation of Estimated Glomerular Filtration Rate, Cholesterol and Triglycerides after Switching from Tenofovir/Emtricitabine plus Atazanavir/Ritonavir (ATV/r) to Abacavir/Lamivudine plus ATV/r in Patients with Preserved Renal Function

Frequency and Treatment-Related Predictors of Thymidine-Analogue Mutation Patterns in HIV-1 Isolates after Unsuccessful Antiretroviral Therapy

Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received

Neurological Symptoms during Primary Human Immunodeficiency Virus (HIV) Infection Correlate with High Levels of HIV RNA in Cerebrospinal Fluid

Risk factors in the development of retinopathy of prematurity: A 10-year retrospective study

Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial

Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients: ATLAS-M substudy

Determinants of HIV-1 genotypic resistance to darunavir (TMC114) in a large Italian resistance database (Antiretroviral Resistance Cohort Analysis)

Ocular involvement in neuroblastoma: not always metastasis

Predictors of poor outcome in tocilizumab treated patients with Sars-CoV-2 related severe respiratory failure: A multicentre real world study

Influence of hepatitis c genotypes on lipid levels in HIV-positive patients during highly active antiretroviral therapy

O-16 Resting-state functional cortical connectivity are abnormal in HIV patients

Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study

Maraviroc 150 mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN study

Aktive Filter

Suchergebnisse filtern